PETALING JAYA: Four cough and fever syrup products produced by a pharmaceutical company in India that led to the death of 66 children in Gambia are not registered here, says Tan Sri Dr Noor Hisham Abdullah.
The Health director-general said a check with the National Pharmacy Regulatory Division (NPRA) database showed no records for promethazine oral solution, kofexmalin baby cough syrup, makoff baby cough syrup and magrip N cold syrup.
The World Health Organization (WHO) issued an alert Wednesday over four cough and cold syrups made by Maiden Pharmaceuticals in India.
The UN health agency also cautioned the contaminated medications may have been distributed outside of the West African country, with global exposure “possible”.
